Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer

NCT00889343 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Sorafenib
DRUG: Placebo
DRUG: Oxaliplatin or Irinotecan
DRUG: Leucovorin
DRUG: 5-Fluorouracil

Sponsor

AIO-Studien-gGmbH